With nearly 150,000 cases identified each year, colorectal cancer remains one of the medical community’s greatest diagnostic challenges. When colorectal cancers are detected at an early, localized stage, the 5-year survival is 91%; however, only 39% of colorectal cancers are diagnosed at this stage, in part due to underuse of screening. After the cancer has spread regioinally to involve adjacent organs or lymph nodes, the 5-year survival drops to 70%. When the disease has spread to distant organs, the 5-year survival is 11%.1
To help improve colorectal cancer screening compliance, physicians should consider the InSure® FIT™ screening test, which offers high sensitivity and ease of use:
InSure® FIT™ is a CLIA waived test available for laboratory services and in-office / point of care (POC) testing. For laboratory services contact your Clinical Genomics sales representative. For in-office / point of care (POC) testing contact one of our distributor partners or Enterix Inc. at 1-800-531-3681.
For more information on the InSure® FIT™ test please complete the Information Request Form and a representative will contact you.
If you are already a user of InSure® FIT™ and are seeking additional information such as Instructions for Use (English or Spanish), Reply Forms (for in-office / POC format only), MSDSs or educational resources please click on the "Resources" link at the top left.